Functional Medicine · Hormonal Health

The Journal

by Dr. Natasha Ryan, ND

Gut Health · Testing

Comprehensive Stool Testing: What It Can Tell You About Bloating, Gut Health, and Inflammation

3 min read

When digestion has been off for months and a standard workup comes back normal, a comprehensive stool test is often the next step in functional medicine. It looks at far more than a routine stool sample does. But not every marker on the report carries the same weight, and knowing the difference keeps you from chasing numbers that don't matter.

What a comprehensive stool test measures

Different labs offer different panels, but most look at some combination of these:

  • Inflammation: calprotectin, and sometimes lactoferrin, which rise when the intestinal lining is inflamed.
  • Infections: parasites, pathogenic bacteria, and yeast, often detected by DNA-based methods.
  • Digestion and absorption: pancreatic elastase, a marker of how well the pancreas is producing digestive enzymes, and fat in the stool.
  • Immune function in the gut: secretory IgA, the antibody that lines the gut.
  • The microbiome: levels of beneficial and potentially problematic bacteria.
  • Other markers: beta-glucuronidase, which affects estrogen recycling, and sometimes zonulin or blood in the stool.

The markers with strong evidence

Some of these are well established in conventional medicine.

Calprotectin is the best example. A 2015 meta-analysis in the American Journal of Gastroenterology found that in adults with IBS-type symptoms, a calprotectin of 40 µg/g or lower meant a 1% or lower chance of inflammatory bowel disease. That's genuinely useful: a normal result helps rule out Crohn's disease and ulcerative colitis, and a high one says you need a gastroenterologist.

Pathogen testing can find infections that explain ongoing symptoms, such as parasites picked up while traveling. Pancreatic elastase is a recognized test for whether the pancreas is making enough digestive enzymes, which matters when there are fatty or floating stools, or weight loss.

The markers that are still exploratory

The microbiome section is where reports are most detailed and the evidence is thinnest. Science hasn't yet defined what a "normal" microbiome looks like for any one person, and levels of individual bacteria vary from day to day. These results are best read as patterns, such as low diversity or a shortage of fiber-fermenting bacteria, rather than as precise diagnoses.

Zonulin, often sold as a leaky gut marker, is another caution. A 2019 study found that two widely used commercial zonulin tests appear to detect other proteins, not zonulin itself. I don't base decisions on a zonulin result alone.

A stool test also can't diagnose SIBO. Bacterial overgrowth in the small intestine needs a breath test, because stool reflects what's happening in the colon.

How I use it

A stool test is most useful when it answers a specific question: Is there inflammation? An infection? Poor digestion? Something on the report that explains why symptoms aren't improving? Read alongside your symptoms, hormones, and other labs, it can turn months of trial and error into a focused plan, and it can show whether that plan is working when it's repeated.

What it shouldn't do is generate a long list of supplements for every out-of-range number. Many microbiome findings improve on their own once the basics are addressed: diet diversity, fiber, fermented foods, sleep, stress, and treating any real infection or inflammation.

When stool testing makes sense

  • Ongoing bloating, gas, diarrhea, or constipation without a clear cause
  • Digestive symptoms alongside skin flares, joint aches, fatigue, or food reactions
  • Symptoms that started after travel, a course of antibiotics, or food poisoning
  • Gut symptoms that haven't improved with diet changes

Some symptoms need a conventional medical evaluation first, and possibly a colonoscopy: blood in the stool, black stools, unintentional weight loss, symptoms that wake you at night, anemia, or a new change in bowel habits after 45.

References

  1. Menees SB, et al. “A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.” American Journal of Gastroenterology, 2015. View source
  2. Ajamian M, et al. “Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems.” PLoS ONE, 2019. View source
  3. Pimentel M, et al. “ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.” American Journal of Gastroenterology, 2020. View source